{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T01:20:02Z","timestamp":1771550402213,"version":"3.50.1"},"reference-count":52,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2006,10,1]],"date-time":"2006-10-01T00:00:00Z","timestamp":1159660800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2006,10,1]],"date-time":"2006-10-01T00:00:00Z","timestamp":1159660800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,12,3]],"date-time":"2022-12-03T00:00:00Z","timestamp":1670025600000},"content-version":"vor","delay-in-days":5907,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["amjtransplant.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Transplantation"],"published-print":{"date-parts":[[2006,10]]},"DOI":"10.1111\/j.1600-6143.2006.01470.x","type":"journal-article","created":{"date-parts":[[2006,7,26]],"date-time":"2006-07-26T04:36:16Z","timestamp":1153888576000},"page":"2348-2355","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":107,"title":["Hepatitis C Recurrence After Liver Transplantation: Viral and Histologic Response to Full-Dose Peg-Interferon and Ribavirin"],"prefix":"10.1016","volume":"6","author":[{"given":"E.","family":"Oton","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Barcena","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.M.","family":"Moreno-Planas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V.","family":"Cuervas-Mons","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Moreno-Zamora","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Barrios","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Garcia-Garzon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Moreno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Boullosa-Gra\u00f1a","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.E.","family":"Rubio-Gonzalez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Garcia-Gonzalez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Blesa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.L.","family":"Mateos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1111\/j.1600-6143.2006.01470.x_bib1","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1053\/gast.2002.32418","article-title":"The association between hepatitis C infection and survival after orthotopic liver transplantation","volume":"122","author":"Forman","year":"2002","journal-title":"Gastroenterology"},{"key":"10.1111\/j.1600-6143.2006.01470.x_bib2","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/S0041-1345(96)00245-X","article-title":"Prospective study of hepatitis C virus infection after orthotopic liver transplantation","volume":"29","author":"Barcena","year":"1997","journal-title":"Transplant Proc"},{"key":"10.1111\/j.1600-6143.2006.01470.x_bib3","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1002\/lt.500060111","article-title":"Prediction of liver allograft fibrosis after transplantation for hepatitis C virus: Persistent elevation of serum transaminase levels versus necroinflammatory activity","volume":"6","author":"Pelletier","year":"2000","journal-title":"Liver Transpl"},{"key":"10.1111\/j.1600-6143.2006.01470.x_bib4","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1002\/hep.510290122","article-title":"High incidence of allograft cirrhosis in HCV genotype 1b following transplantation: Relationship with rejection episodes","volume":"29","author":"Prieto","year":"1999","journal-title":"Hepatology"},{"key":"10.1111\/j.1600-6143.2006.01470.x_bib5","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1016\/j.jhep.2004.06.029","article-title":"Fibrosis progression after liver transplantation in patients with recurrent hepatitis C","volume":"41","author":"Neumann","year":"2004","journal-title":"J Hepatol"},{"key":"10.1111\/j.1600-6143.2006.01470.x_bib6","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1053\/jhep.2002.33993","article-title":"Contribution of donors age to the recent decrease in percents survival among HCV-infected liver transplant recipients","volume":"36","author":"Berenguer","year":"2002","journal-title":"Hepatology"},{"key":"10.1111\/j.1600-6143.2006.01470.x_bib7","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1097\/00007890-200201150-00010","article-title":"Impact of recurrence of hepatitis C virus infection after liver transplantation on the long term viability of the graft","volume":"73","author":"Sanchez Fueyo","year":"2002","journal-title":"Transplantation"},{"key":"10.1111\/j.1600-6143.2006.01470.x_bib8","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/S0168-8278(00)80231-7","article-title":"HCV-related fibrosis progression following liver transplantation: Increase in recent years","volume":"32","author":"Berenguer","year":"2000","journal-title":"J Hepatol"},{"key":"10.1111\/j.1600-6143.2006.01470.x_bib9","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1136\/gut.51.2.248","article-title":"Advancing donor liver age and rapid fibrosis progression following transplantation for hepatitis C","volume":"51","author":"Wali","year":"2002","journal-title":"Gut"},{"key":"10.1111\/j.1600-6143.2006.01470.x_bib10","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/S0140-6736(96)07642-8","article-title":"Natural history of liver fibrosis progression in patients with chronic hepatitis C","volume":"349","author":"Poynard","year":"1997","journal-title":"Lancet"},{"key":"10.1111\/j.1600-6143.2006.01470.x_bib11","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1002\/hep.1840220411","article-title":"An open trial of interferon alfa recombinant for hepatitis C after liver transplantation: Antiviral effects and risk of rejection","volume":"22","author":"Feray","year":"1995","journal-title":"Hepatology"},{"key":"10.1111\/j.1600-6143.2006.01470.x_bib12","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1053\/gast.2003.50095","article-title":"Interferon alfa 2b plus ribavirin in patients with chronic hepatitis C after liver transplantation: A randomised study","volume":"124","author":"Samuel","year":"2003","journal-title":"Gastroenterology"},{"key":"10.1111\/j.1600-6143.2006.01470.x_bib13","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1016\/0168-8278(95)80226-6","article-title":"Histological grading and staging of chronic hepatitis","volume":"22","author":"Ishak","year":"1995","journal-title":"J Hepatol"},{"key":"10.1111\/j.1600-6143.2006.01470.x_bib14","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1002\/hep.20119","article-title":"Diagnosis, management and treatment of hepatitis C","volume":"39","author":"Strader","year":"2004","journal-title":"Hepatology"},{"key":"10.1111\/j.1600-6143.2006.01470.x_bib15","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1097\/01.TP.0000155424.52939.3D","article-title":"Partial esplenic embolization for the treatment of hypersplenism in liver transplanted patients with hepatitis C virus recurrence before peg-interferon plus ribavirin","volume":"79","author":"Barcena","year":"2005","journal-title":"Transplantation"},{"key":"10.1111\/j.1600-6143.2006.01470.x_bib16","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1056\/NEJMoa020047","article-title":"Peginterferon alfa 2a plus ribavirin for chronic hepatitis C virus infection","volume":"347","author":"Fried","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1600-6143.2006.01470.x_bib17","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1086\/376971","article-title":"Hematologic disorders associated with hepatitis C virus infection and their management","volume":"37","author":"Dieterich","year":"2003","journal-title":"Clin Infect Dis"},{"key":"10.1111\/j.1600-6143.2006.01470.x_bib18","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1097\/01.TP.0000100481.14514.BB","article-title":"Treatment of recurrent hepatitis C infection after liver transplantation with combination of pegylated interferon alpha2b and ribavirin: An open-label series","volume":"77","author":"Rodriguez-Luna","year":"2004","journal-title":"Transplantation"},{"key":"10.1111\/j.1600-6143.2006.01470.x_bib19","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/j.jhep.2003.12.015","article-title":"Treatment of recurrent hepatitis C after liver transplantation: A pilot study of peginterferon alfa-2b and ribavirin combination","volume":"40","author":"Dumortier","year":"2004","journal-title":"J Hepatol"},{"key":"10.1111\/j.1600-6143.2006.01470.x_bib20","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1097\/01.TP.0000129811.93072.1C","article-title":"Treatment of established recurrent hepatitis C in liver-transplant recipients with pegylated interferon-alfa-2b and ribavirin therapy","volume":"78","author":"Neff","year":"2004","journal-title":"Transplantation"},{"key":"10.1111\/j.1600-6143.2006.01470.x_bib21","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1111\/j.1440-1746.2005.03795.x","article-title":"Pegylated versus standard interferon-alfa in antiviral regimens for post-transplant recurrent hepatitis C: Comparison of tolerability and efficacy","volume":"20","author":"Toniutto","year":"2005","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1111\/j.1600-6143.2006.01470.x_bib22","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1111\/j.1600-6143.2004.00648.x","article-title":"Applicability tolerability and efficacy of preemptive antiviral therapy in hepatitis C-infected patients undergoing liver transplantation","volume":"5","author":"Shergill","year":"2005","journal-title":"Am J Transplant"},{"key":"10.1111\/j.1600-6143.2006.01470.x_bib23","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1155\/2005\/745197","article-title":"Pegylated interferon alpha 2b and ribavirin for recurrent hepatitis C after liver transplantation: From a Canadian experience to recommendations for therapy","volume":"19","author":"Babatin","year":"2005","journal-title":"Can J Gastroenterol"},{"key":"10.1111\/j.1600-6143.2006.01470.x_bib24","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.dld.2005.08.009","article-title":"Pegylated interferon plus ribavirin for recurrent hepatitis C infection after liver transplantation in naive and non-responder patients on a stable immunosuppressive regimen","volume":"38","author":"Biselli","year":"2006","journal-title":"Dig Liv Dis"},{"key":"10.1111\/j.1600-6143.2006.01470.x_bib25","doi-asserted-by":"crossref","first-page":"3963","DOI":"10.1016\/j.transproceed.2005.10.060","article-title":"Pegylated interferon and ribavirin for the recurrence of chronic hepatitis C genotype 1 in transplant patients","volume":"37","author":"Oton","year":"2005","journal-title":"Transplant Proc"},{"key":"10.1111\/j.1600-6143.2006.01470.x_bib26","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1002\/hep.510280334","article-title":"The efficacy of prophylactic interferon alfa 2b in preventing recurrent hepatitis C after liver transplantation","volume":"28","author":"Sheiner","year":"1998","journal-title":"Hepatology"},{"key":"10.1111\/j.1600-6143.2006.01470.x_bib27","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1097\/00007890-199801150-00016","article-title":"Interferon-alpha for prophylaxis of recurrent viral hepatitis C in liver transplant patients: a prospective randomized controlled trial","volume":"65","author":"Singh","year":"1998","journal-title":"Transplantation"},{"key":"10.1111\/j.1600-6143.2006.01470.x_bib28","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1002\/hep.20560","article-title":"Peginterferon alfa-2a for hepatitis C after liver transplantation: Two randomized, controlled trials","volume":"41","author":"Chalasani","year":"2005","journal-title":"Hepatology"},{"key":"10.1111\/j.1600-6143.2006.01470.x_bib29","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.jhep.2005.02.015","article-title":"Combined treatment with pegylated interferon (alfa-2b) and ribavirin in the acute phase of hepatitis C virus recurrence after liver transplantation","volume":"43","author":"Castells","year":"2005","journal-title":"J Hepatol"},{"key":"10.1111\/j.1600-6143.2006.01470.x_bib30","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1046\/j.1399-0012.2003.00145.x","article-title":"Pegylated interferon alpha-2b plus ribavirin in the treatment of post-liver transplant recurrent hepatitis C","volume":"18","author":"Ross","year":"2004","journal-title":"Clin Transplant"},{"key":"10.1111\/j.1600-6143.2006.01470.x_bib31","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1016\/j.jhep.2005.05.019","article-title":"HCV clearance and treatment outcome in genotype 1 HCV-monoinfected and liver transplanted patients on peg-IFN-\u03b1-2b\/ribavirin","volume":"43","author":"Moreno","year":"2005","journal-title":"J Hepatol"},{"key":"10.1111\/j.1600-6143.2006.01470.x_bib32","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1002\/lt.20157","article-title":"Outcomes of acute rejection after interferon therapy in liver transplant recipients","volume":"10","author":"Saab","year":"2004","journal-title":"Liver Transpl"},{"key":"10.1111\/j.1600-6143.2006.01470.x_bib33","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1080\/1042819021000055066","article-title":"Vascular events associated with alpha interferon therapy","volume":"44","author":"Al-Zahrani","year":"2003","journal-title":"Leuk Lymphoma"},{"key":"10.1111\/j.1600-6143.2006.01470.x_bib34","doi-asserted-by":"crossref","first-page":"2583","DOI":"10.1002\/(SICI)1097-0142(19990615)85:12<2583::AID-CNCR14>3.0.CO;2-#","article-title":"Thrombotic microangiopathy associated with interferon therapy for patients with chronic myelogenous leukemia: Coincidence or true side effect?","volume":"85","author":"Ravandi-Kashani","year":"1999","journal-title":"Cancer"},{"key":"10.1111\/j.1600-6143.2006.01470.x_bib35","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/0002-9343(93)90242-H","article-title":"Thrombosis and recombinant interferon-alpha","volume":"95","author":"Durand","year":"1993","journal-title":"Am J Med"},{"key":"10.1111\/j.1600-6143.2006.01470.x_bib36","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1097\/01.TP.0000135566.33051.35","article-title":"Hepatic artery stenosis in liver transplanted patients treated with pegylated interferon alpha-2b and ribavirin","volume":"78","author":"Biselli","year":"2004","journal-title":"Transplantation"},{"key":"10.1111\/j.1600-6143.2006.01470.x_bib37","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1097\/00007890-198802000-00031","article-title":"Adverse effect of low-dose prophylactic human recombinant leukocyte interferon-alfa treatment in renal transplant recipients. Cytomegalovirus infection prophylaxis leading to an increased incidence of irreversible rejections","volume":"45","author":"Kovarik","year":"1988","journal-title":"Transplantation"},{"key":"10.1111\/j.1600-6143.2006.01470.x_bib38","doi-asserted-by":"crossref","unstructured":"Kramer P, Ten Kate FW, Bijnen AB, Jeekel J, Weimar W. Recombinant leucocyte interferon A induces steroid-resistant acute vascular rejection episodes in renal transplant recipients. Lancet 1984; 989\u2013990.","DOI":"10.1016\/S0140-6736(84)92327-4"},{"key":"10.1111\/j.1600-6143.2006.01470.x_bib39","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1002\/hep.510260236","article-title":"Pilot study of the combination of interferon alfa and ribavirin as therapy of recurrent hepatitis C after liver transplantation","volume":"26","author":"Bizollon","year":"1997","journal-title":"Hepatology"},{"key":"10.1111\/j.1600-6143.2006.01470.x_bib40","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1002\/lt.20189","article-title":"Effects of interferon treatment on liver histology and allograft rejection in patients with recurrent hepatitis following liver transplantation","volume":"10","author":"Stravitz","year":"2004","journal-title":"Liver Transpl"},{"key":"10.1111\/j.1600-6143.2006.01470.x_bib41","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1111\/j.1600-6143.2005.00976.x","article-title":"Benefit of sustained virological response to combination therapy on graft survival of liver transplanted patients with recurrent chronic hepatitis C","volume":"5","author":"Bizollon","year":"2005","journal-title":"Am J Transpl"},{"key":"10.1111\/j.1600-6143.2006.01470.x_bib42","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1053\/jlts.2002.34968","article-title":"Combination of interferon alfa-2b and ribavirin in liver transplant recipients with histological recurrent hepatitis C","volume":"8","author":"Firpi","year":"2002","journal-title":"Liver Transpl"},{"key":"10.1111\/j.1600-6143.2006.01470.x_bib43","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1136\/gut.52.2.283","article-title":"Long-term histological improvement and clearance of intrahepatic hepatitis C virus RNA following sustained response to interferon-ribavirin combination therapy in liver transplanted patients with hepatitis C virus recurrence","volume":"52","author":"Bizollon","year":"2003","journal-title":"Gut"},{"key":"10.1111\/j.1600-6143.2006.01470.x_bib44","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1053\/j.gastro.2005.06.031","article-title":"Suppression of hepatitis C virus replication by cyclosporin A is mediated by blockade of cyclophilins","volume":"129","author":"Nakagawa","year":"2005","journal-title":"Gastroenterology"},{"key":"10.1111\/j.1600-6143.2006.01470.x_bib45","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1053\/jhep.2003.50449","article-title":"Cyclosporin A suppresses replication of hepatitis C virus genome in cultured hepatocytes","volume":"38","author":"Watashi","year":"2003","journal-title":"Hepatology"},{"key":"10.1111\/j.1600-6143.2006.01470.x_bib46","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1002\/lt.20532","article-title":"Cyclosporine suppresses hepatitis C virus in vitro and increases the chance of a sustained virological response after liver transplantation","volume":"12","author":"Firpi","year":"2006","journal-title":"Liver Transpl"},{"key":"10.1111\/j.1600-6143.2006.01470.x_bib47","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1053\/jlts.2001.27803","article-title":"Histological recurrence and progression of hepatitis C after orthotopic liver transplantation: Influence of immunosuppressive regimens","volume":"7","author":"Hunt","year":"2001","journal-title":"Liver Transpl"},{"key":"10.1111\/j.1600-6143.2006.01470.x_bib48","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1097\/00007890-200108150-00009","article-title":"The role of different immunosuppression in the long-term histological outcome of HCV reinfection after liver transplantation for HCV cirrhosis","volume":"72","author":"Papatheodoridis","year":"2001","journal-title":"Transplantation"},{"key":"10.1111\/j.1600-6143.2006.01470.x_bib49","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1053\/jlts.2000.9741","article-title":"Liver transplantation for hepatitis C: Recurrence and disease progression in 300 patients","volume":"6","author":"Testa","year":"2000","journal-title":"Liver Transpl"},{"key":"10.1111\/j.1600-6143.2006.01470.x_bib50","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1097\/01.TP.0000088668.28950.7C","article-title":"Progression of liver fibrosis in patients with chronic hepatitis C after orthotopic liver transplantation","volume":"76","author":"Chopra","year":"2003","journal-title":"Transplantation"},{"key":"10.1111\/j.1600-6143.2006.01470.x_bib51","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1002\/lt.20344","article-title":"Immunosuppression and donor age with respect to severity of HCV recurrence after liver transplantation","volume":"11","author":"Samonakis","year":"2005","journal-title":"Liver Transpl"},{"key":"10.1111\/j.1600-6143.2006.01470.x_bib52","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1097\/01.TP.0000101738.27552.9D","article-title":"Long-term outcome of liver transplants for chronic hepatitis C: A 10-year follow-up","volume":"77","author":"Neumann","year":"2004","journal-title":"Transplantation"}],"container-title":["American Journal of Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1600-6143.2006.01470.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1600613522028301?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1600613522028301?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1600-6143.2006.01470.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T04:38:32Z","timestamp":1761626312000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1600613522028301"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,10]]},"references-count":52,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2006,10]]}},"alternative-id":["S1600613522028301"],"URL":"https:\/\/doi.org\/10.1111\/j.1600-6143.2006.01470.x","relation":{},"ISSN":["1600-6135"],"issn-type":[{"value":"1600-6135","type":"print"}],"subject":[],"published":{"date-parts":[[2006,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hepatitis C Recurrence After Liver Transplantation: Viral and Histologic Response to Full-Dose Peg-Interferon and Ribavirin","name":"articletitle","label":"Article Title"},{"value":"American Journal of Transplantation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1111\/j.1600-6143.2006.01470.x","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2006 American Society of Transplantation & American Society of Transplant Surgeons. Published by Elsevier Inc. All rights reserved. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}